PPARGC1A and neoplasm: Despite reports suggesting a pro-tumorigenic role for elevated PGC1α in subsets of CRC [37], our clinicopathological analyses of 121 paired samples demonstrate that reduced PGC1α expression correlates with advanced tumor stages and poor prognosis.